Investing in companies with a competitive edge. Part 1: The bargaining power of buyers

Tim Richardson

Pengana Capital Group

When buyers hold more concentration, they have the upper hand in negotiating prices and quality. This is particularly relevant in pharmaceuticals, where the US faces high drug prices due to low buyer concentration. But recent changes, like the Inflation Reduction Act, could shift this dynamic, potentially driving prices down.

The renowned Five Forces framework developed by Harvard University professor Michael Porter is a robust framework for analysing competitive edge in any industry. 

In the first installment of Harding Loevner's video series, David Glickman Co-Deputy Director of Research, breaks down the concept of 'the bargaining power of buyers' in industries like healthcare. 

In the next installment, Tim Kubarych Co-Deputy Director of Research, delves into the intricate interplay between industries and their suppliers.

To gain further insight into Harding Loevner's methodology, we invite you to watch the full video series here. 


Tim Richardson
Investment Specialist
Pengana Capital Group
I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment